Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123167) titled 'Standardized Diagnosis and Treatment of Immunocompromised Host Pneumonia and the Establishment of Clinical Pathways' on April 22.
Study Type: Interventional study
Study Design:
Cluster randomization
Primary Sponsor: The First Affiliated Hospital of Guangzhou Medical University
Condition:
immuno-compromised host pneumonia
Intervention:
Clinical pathway group:A multidisciplinary team (MDT) develops and executes a standardized clinical pathway, covering six key steps and 24 criteria, to optimize the diagnosis and treatment process, improve the accuracy of etiological diagnosis, fine-tune treatment regimens, and...